inactivating mutations acetyltransferase genes b-cell lymphoma 
b-cell non-hodgkins lymphoma comprises biologically clinically distinct diseases pathogenesis associated genetic lesions affecting oncogenes tumour-suppressor genes report two common types-follicular lymphoma diffuse large b-cell lymphoma-harbour frequent structural alterations inactivating crebbp rarely ep300 two highly related histone non-histone acetyltransferases hats act transcriptional co-activators multiple signalling pathways overall % diffuse large b-cell lymphoma % follicular lymphoma cases display genomic deletions and/or somatic mutations remove inactivate hat coding domain two genes lesions usually affect one allele suggesting reduction hat dosage important lymphomagenesis demonstrate specific defects acetylation-mediated inactivation bcl6 oncoprotein activation p53 tumour suppressor results identify crebbp/ep300 mutations major pathogenetic mechanism shared common forms b-cell non-hodgkins lymphoma direct implications use drugs targeting acetylation/deacetylation mechanisms 
